216 related articles for article (PubMed ID: 27750201)
21. Click-based synthesis and antitubercular evaluation of dibenzofuran tethered thiazolyl-1,2,3-triazolyl acetamides.
Surineni G; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2016 Aug; 26(15):3684-9. PubMed ID: 27317646
[TBL] [Abstract][Full Text] [Related]
22. Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations.
Tripathi RP; Yadav AK; Ajay A; Bisht SS; Chaturvedi V; Sinha SK
Eur J Med Chem; 2010 Jan; 45(1):142-8. PubMed ID: 19846238
[TBL] [Abstract][Full Text] [Related]
23. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
[TBL] [Abstract][Full Text] [Related]
26. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
[TBL] [Abstract][Full Text] [Related]
27. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Papadopoulou MV; Bloomer WD; Rosenzweig HS
Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
[TBL] [Abstract][Full Text] [Related]
28. A click chemistry approach for the synthesis of cyclic ureido tethered coumarinyl and 1-aza coumarinyl 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis H37Rv and their in silico studies.
Khanapurmath N; Kulkarni MV; Joshi SD; Anil Kumar GN
Bioorg Med Chem; 2019 Oct; 27(20):115054. PubMed ID: 31471101
[TBL] [Abstract][Full Text] [Related]
29. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
[TBL] [Abstract][Full Text] [Related]
30. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
[TBL] [Abstract][Full Text] [Related]
32. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
[TBL] [Abstract][Full Text] [Related]
33. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2017 Dec; 27(23):5119-5121. PubMed ID: 29113761
[TBL] [Abstract][Full Text] [Related]
35. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities.
Ding Z; Hou P; Liu B
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087
[TBL] [Abstract][Full Text] [Related]
36. Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agents.
Cao Y; Lu H
Future Med Chem; 2021 Dec; 13(23):2107-2124. PubMed ID: 34698509
[TBL] [Abstract][Full Text] [Related]
37. Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Chollet A; Rodriguez F; Inard C; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2012 Jun; 52():275-83. PubMed ID: 22483635
[TBL] [Abstract][Full Text] [Related]
38. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
[TBL] [Abstract][Full Text] [Related]
39. Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents.
Singh BK; Yadav AK; Kumar B; Gaikwad A; Sinha SK; Chaturvedi V; Tripathi RP
Carbohydr Res; 2008 May; 343(7):1153-62. PubMed ID: 18346719
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of new triazolobenzothiazole derivatives as potential anti-tubercular agents.
Paranjape SD; Bobade AS; Khadse BG
Arzneimittelforschung; 2001 Nov; 51(11):916-9. PubMed ID: 11765594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
